Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chromadex Corp CDXC

Technology Scientific & Technical Instruments
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished... see more

Recent & Breaking News (NDAQ:CDXC)

ChromaDex to Report First Quarter 2017 Financial Results on Thursday, May 11, 2017

GlobeNewswire May 4, 2017

ChromaDex Announces Strategic Investment Led by Mr. Li Ka-shing

GlobeNewswire April 27, 2017

ChromaDex to Showcase Novel Ingredient Science and Brand-Elevating Services at Ingredient Marketplace 2017

GlobeNewswire April 11, 2017

ChromaDex to Present at the Cowen and Company’s 3rd Annual Future of the Consumer Conference: Convergence & Disruption on April 4, 2017

GlobeNewswire March 29, 2017

ChromaDex Appoints Steven D. Rubin, J.D., to its Board of Directors

GlobeNewswire March 28, 2017

ChromaDex Reports 2016 Record Revenue as Ingredient Sales Grew 34%

GlobeNewswire March 16, 2017

ChromaDex to Report Year End 2016 Financial Results on Thursday, March 16, 2017

GlobeNewswire March 10, 2017

A Letter from the ChromaDex Chief Executive Officer

GlobeNewswire February 23, 2017

Study Published in PAIN Reveals Nicotinamide Riboside is an Effective Tool in Relieving Chemotherapy-Induced Peripheral Neuropathy Induced by a Common Anticancer Agent

GlobeNewswire February 22, 2017

ChromaDex to Showcase Premier Innovation and Brand-Elevating Science at Engredea 2017

GlobeNewswire February 21, 2017

ChromaDex Expects to Report Record Fourth Quarter as Revenue Increased Approximately 29%

GlobeNewswire February 14, 2017

ChromaDex Opens New State-of-the-Art Research and Development Center in Longmont

GlobeNewswire January 5, 2017

ChromaDex to Present at the ICR Conference 2017 on January 11, 2017

GlobeNewswire January 4, 2017

ChromaDex to Present at the 3rd Annual Bernstein Consumer Summit on December 8, 2016

GlobeNewswire December 1, 2016

ChromaDex Announces the Results of Pre-IND meeting for Nicotinamide Riboside for Cockayne Syndrome

GlobeNewswire November 11, 2016

ChromaDex Reports Third Quarter 2016 Financial Results

GlobeNewswire November 10, 2016

ChromaDex Establishes $5 Million Credit Facility with Bridge Bank

GlobeNewswire November 8, 2016

ChromaDex Names Dr. Matthew Roberts as a New Scientific Advisory Board Member

GlobeNewswire November 7, 2016

ChromaDex to Attend the Torrey Hills Capital 2nd Annual Emerging Growth Conference on November 11, 2016

GlobeNewswire November 4, 2016

ChromaDex to Report Third Quarter 2016 Financial Results on Thursday, November 10, 2016

GlobeNewswire November 3, 2016